GGrantIndex
← Search

CCTN - MALE CONTRACEPTIVE TRIAL DMAU-SEDDS STUDY

$260,818N01FY2014HDNIH

University Of Washington, Seattle WA

Investigators

Abstract

Phase I Male Contraceptive Trial, Dimethylandrolone undecanoatehase (DMAU), shown in animal studies to inhibit spermatogenesis. Test single dose in man.

View original record on NIH RePORTER →